| Characteristics | All |
| Number | 374 |
| Mean Age, years (SD) | 35.2 (10.5) |
| Female Sex | 342 (92%) |
| Race/Ethnicity | All |
| White | 289 (77%) |
| Latinx | 49 (13%) |
| Black-African American | 21 (6%) |
| Asian | 15 (4%) |
| Black-African |
14 (4%) |
| Other | 10 (3%) |
| Comorbidities | All |
| Obesity | 229 (62%) |
| Pulmonary disease | 113 (30%) |
| Tobacco smoking | 70 (19%) |
| Diabetes | 26 (7%) |
| CV disease | 8 (2%) |
| COVID-19 Medications | All |
| No treatment | 244 (65%) |
| Azithromycin | 49 (15%) |
| Corticosteroids | 45 (12%) |
| Oxygen supplementation | 27 (7%) |
| Anti-viral | 14 (3%) |
| Anti-malarial | 9 (2%) |
| IL-6 inhibitor | 1 (1%) |
| COVID-19 Complications | All |
| No serious events | 199 (53%) |
| HS flare | 130 (35%) |
| Shortness of breath | 54 (15%) |
| Sepsis | 5 (1%) |
| Death | 0 (0%) |
| COVID-19 Treatment Location | All |
| In hospital treatment | 27 (7%) |
| ED treatment | 49 (15%) |
| Home | 316 (84%) |